CCDC18 and cancer: In other words, we identified higher expression of 2.366-fold of SFN (|LogFC| = 1.243), 12.915-fold of LINC01343 (|logFC| = 3.691), and 10.584-fold of CCDC18-AS1 (|logFC| = 3.397) in the cancer tissue in comparison to the control group.